In a memo, Dr Walford stated Dr Smith had "carefully worded [the] recommendation" of the CSM paper and "that supply of material must take precedence over [the] implementation [of CSM(B)'s recommendation]."
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr Diana Walford